Identification of the key immune gene NR3C1 as a diagnostic biomarker in differentiating ovarian borderline tumors from benign tumors
Our study findings suggested that NR3C1 may serve as an immune-related diagnostic biomarker for BOTs, offering a novel perspective for investigating the development and diagnosis of BOTs.
Authors
- Liying Sheng (ORCID: https://orcid.org/0000-0002-8361-9751)
- Li Huang (ORCID: https://orcid.org/0000-0001-8448-3481)
- Zhuna Wu
- Shunlan Liu (ORCID: https://orcid.org/0000-0003-3237-6195)
- Yumin Ke
- Weihong Chen (ORCID: https://orcid.org/0000-0001-8689-7311)
- Shiying Chen
- Yueli Wang
- Yajing Xie
- Zhimei Zhou
Institutions
- Fujian Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Frontiers in Cell and Developmental Biology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.3389/fcell.2025.1602192
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70